Innovative treatment for blood cancer patient in Thailand with non viral based CD-19 Chimeric Antigen Receptor T cell: Phase I clinical trial June 5, 2023 admin 0 Research Topics Innovative treatment for blood cancer patient in Thailand with non viral based CD-19 Chimeric Antigen Receptor T cell: Phase I clinical trial Researchers Kormait Suppipat Institute Chulalongkorn University Funding Health Systems Research Institute (NSRI) Timeline 2022-2023 Facebook Twitter Line Tags: Chulalongkorn University